Correction: CheckMate for advanced-stage ccRCC? Nivolumab and cabozantinib aMETEORate poor survival
Crossref DOI link: https://doi.org/10.1038/nrclinonc.2015.207
Published Online: 2015-11-10
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Thoma, Clemens
Text and Data Mining valid from 2015-11-10
Article History
First Online: 10 November 2015